Table of Contents Author Guidelines Submit a Manuscript
International Journal of Genomics
Volume 2017 (2017), Article ID 4858173, 12 pages
https://doi.org/10.1155/2017/4858173
Research Article

The Transcriptional Network Structure of a Myeloid Cell: A Computational Approach

1Computational Genomics Division, National Institute of Genomic Medicine, 14610 México City, Mexico
2Centro de Ciencias de la Complejidad, Universidad Nacional Autónoma de México, 04510 México City, Mexico

Correspondence should be addressed to Enrique Hernández-Lemus; xm.bog.negemni@zednanrehe

Received 2 February 2017; Revised 28 July 2017; Accepted 9 August 2017; Published 30 September 2017

Academic Editor: Graziano Pesole

Copyright © 2017 Jesús Espinal-Enríquez et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. Ravasi, H. Suzuki, C. V. Cannistraci et al., “An atlas of combinatorial transcriptional regulation in mouse and man,” Cell, vol. 140, no. 5, pp. 744–752, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. K. Baca-López, M. Mayorga, A. Hidalgo-Miranda, N. Gutiérrez-Nájera, and E. Hernández-Lemus, “The role of master regulators in the metabolic/transcriptional coupling in breast carcinomas,” PLoS One, vol. 7, no. 8, article e42678, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. J. H. Woo, Y. Shimoni, W. S. Yang et al., “Elucidating compound mechanism of action by network perturbation analysis,” Cell, vol. 162, no. 2, pp. 441–451, 2015. View at Publisher · View at Google Scholar · View at Scopus
  4. H. Tovar, R. García-Herrera, J. Espinal-Enríquez, and E. Hernández-Lemus, “Transcriptional master regulator analysis in breast cancer genetic networks,” Computational Biology and Chemistry, vol. 59, Part B, pp. 67–77, 2015. View at Publisher · View at Google Scholar · View at Scopus
  5. A. A. Margolin, I. Nemenman, K. Basso et al., “ARACNE: an algorithm for the reconstruction of gene regulatory networks in a mammalian cellular context,” BMC Bioinformatics, vol. 7, Supplement 1, p. S7, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. J. M. Vaquerizas, S. K. Kummerfeld, S. A. Teichmann, and N. M. Luscombe, “A census of human transcription factors: function, expression and evolution,” Nature Reviews Genetics, vol. 10, no. 4, pp. 252–263, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. U. Alon, “Network motifs: theory and experimental approaches,” Nature Reviews Genetics, vol. 8, no. 6, pp. 450–461, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. FANTOM Consortium, H. Suzuki, A. R. Forrest et al., “The transcriptional network that controls growth arrest and differentiation in a human myeloid leukemia cell line,” Nature Genetics, vol. 41, no. 5, pp. 553–562, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. S. Gama-Castro, H. Salgado, A. Santos-Zavaleta et al., “RegulonDB version 9.0: high-level integration of gene regulation, coexpression, motif clustering and beyond,” Nucleic Acids Research, vol. 44, no. D1, pp. D133–D143, 2015. View at Publisher · View at Google Scholar · View at Scopus
  10. J. Y. Chan, X. L. Han, and Y. W. Kan, “Cloning of Nrf1, an NF-E2-related transcription factor, by genetic selection in yeast,” Proceedings of the National Academy of Sciences, vol. 90, no. 23, pp. 11371–11375, 1993. View at Publisher · View at Google Scholar · View at Scopus
  11. N. C. Andrews, H. Erdjument-Bromage, M. B. Davidson, P. Tempst, and S. H. Orkin, “Erythroid transcription factor NF-E2 is a haematopoietic-specific basic-leucine zipper protein,” Nature, vol. 362, no. 6422, pp. 722–728, 1993. View at Publisher · View at Google Scholar
  12. M. Bugno, M. Daniel, N. L. Chepelev, and W. G. Willmore, “Changing gears in Nrf1 research, from mechanisms of regulation to its role in disease and prevention,” Biochimica et Biophysica Acta (BBA)-Gene Regulatory Mechanisms, vol. 1849, no. 10, pp. 1260–1276, 2015. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Mohrin, J. Shin, Y. Liu et al., “A mitochondrial UPR-mediated metabolic checkpoint regulates hematopoietic stem cell aging,” Science, vol. 347, no. 6228, pp. 1374–1377, 2015. View at Publisher · View at Google Scholar · View at Scopus
  14. D. V. Ho and J. Y. Chan, “Induction of herpud1 expression by ER stress is regulated by Nrf1,” FEBS Letters, vol. 589, no. 5, pp. 615–620, 2015. View at Publisher · View at Google Scholar · View at Scopus
  15. V. O. Okoh, N. A. Garba, R. B. Penney et al., “Redox signalling to nuclear regulatory proteins by reactive oxygen species contributes to oestrogen-induced growth of breast cancer cells,” British Journal of Cancer, vol. 112, no. 10, pp. 1687–1702, 2015. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Biswas, D. Phan, M. Watanabe, and J. Y. Chan, “The Fbw7 tumor suppressor regulates nuclear factor E2-related factor 1 transcription factor turnover through proteasome-mediated proteolysis,” Journal of Biological Chemistry, vol. 286, no. 45, pp. 39282–39289, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. J. Zhang, X. Zheng, and Q. Zhang, “Egln2 positively regulates mitochondrial function in breast cancer,” Molecular & Cellular Oncology, vol. 3, no. 2, article e1120845, 2015. View at Publisher · View at Google Scholar
  18. L. Zhao, M. Tang, Z. Hu et al., “mir-504 mediated down-regulation of nuclear respiratory factor 1 leads to radio-resistance in nasopharyngeal carcinoma,” Oncotarget, vol. 6, no. 18, pp. 15995–16018, 2015. View at Publisher · View at Google Scholar
  19. Y. Zhang and J. D. Hayes, “The membrane-topogenic vectorial behaviour of Nrf1 controls its post-translational modification and transactivation activity,” Scientific Reports, vol. 3, no. 1, article 2006, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. Y. Zhang, J. M. Lucocq, and J. D. Hayes, “The Nrf1 CNC/bZIP protein is a nuclear envelope-bound transcription factor that is activated by t-butyl hydroquinone but not by endoplasmic reticulum stressors,” Biochemical Journal, vol. 418, no. 2, pp. 293–310, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. Y. Zhang, Y. Ren, S. Li, and J. D. Hayes, “Transcription factor Nrf1 is topologically repartitioned across membranes to enable target gene transactivation through its acidic glucose-responsive domains,” PLoS One, vol. 9, no. 4, article e93458, 2014. View at Publisher · View at Google Scholar · View at Scopus
  22. S. Gallant and G. Gilkeson, “ETS transcription factors and regulation of immunity,” Archivum Immunologiae et Therapiae Experimentalis, vol. 54, no. 3, pp. 149–163, 2006. View at Publisher · View at Google Scholar · View at Scopus
  23. Y. Zhou, X. Liu, L. Xu et al., “Transcriptional repression of plasma cell differentiation is orchestrated by aberrant overexpression of the ETS factor SPIB in Waldenström macroglobulinaemia,” British Journal of Haematology, vol. 166, no. 5, pp. 677–689, 2014. View at Publisher · View at Google Scholar · View at Scopus
  24. Y. Yang, A. L. Shaffer 3rd, N. C. Emre et al., “Exploiting synthetic lethality for the therapy of ABC diffuse large B cell lymphoma,” Cancer Cell, vol. 21, no. 6, pp. 723–737, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. J. J. Karrich, M. Balzarolo, H. Schmidlin et al., “The transcription factor Spi-B regulates human plasmacytoid dendritic cell survival through direct induction of the antiapoptotic gene BCL2-A1,” Blood, vol. 119, no. 22, pp. 5191–5200, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. L. J. Marshall, L. D. Moore, M. M. Mirsky, and E. O. Major, “JC virus promoter/enhancers contain TATA box-associated Spi-B-binding sites that support early viral gene expression in primary astrocytes,” Journal of General Virology, vol. 93, Part 3, pp. 651–661, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. W. Su, J. Xia, X. Chen et al., “Ectopic expression of AP-2α transcription factor suppresses glioma progression,” International Journal of Clinical and Experimental Pathology, vol. 7, no. 12, pp. 8666–8674, 2014. View at Google Scholar
  28. A. R. Hallberg, S. U. Vorrink, D. R. Hudachek et al., “Aberrant CpG methylation of the TFAP2A gene constitutes a mechanism for loss of TFAP2A expression in human metastatic melanoma,” Epigenetics, vol. 9, no. 12, pp. 1641–1647, 2014. View at Publisher · View at Google Scholar · View at Scopus
  29. D. Shi, F. Xie, Y. Zhang et al., “TFAP2A regulates nasopharyngeal carcinoma growth and survival by targeting HIF-1α signaling pathway,” Cancer Prevention Research, vol. 7, no. 2, pp. 266–277, 2014. View at Publisher · View at Google Scholar · View at Scopus
  30. H. Li, R. Sheridan, and T. Williams, “Analysis of TFAP2A mutations in branchio-oculo-facial syndrome indicates functional complexity within the AP-2α DNA-binding domain,” Human Molecular Genetics, vol. 22, no. 16, pp. 3195–3206, 2013. View at Publisher · View at Google Scholar · View at Scopus
  31. T. I. Meshcheryakova, R. A. Zinchenko, T. A. Vasilyeva et al., “A clinical and molecular analysis of branchio-oculo-facial syndrome patients in Russia revealed new mutations in TFAP2A,” Annals of Human Genetics, vol. 79, no. 2, pp. 148–152, 2015. View at Publisher · View at Google Scholar · View at Scopus
  32. H. Kawata, K. Yamada, Z. Shou et al., “Zinc-fingers and homeoboxes (ZHX) 2, a novel member of the ZHX family, functions as a transcriptional repressor,” Biochemical Journal, vol. 373, Part 3, pp. 747–757, 2003. View at Publisher · View at Google Scholar · View at Scopus
  33. F. Luan, P. Liu, H. Ma et al., “Reduced nucleic ZHX2 involves in oncogenic activation of glypican 3 in human hepatocellular carcinoma,” The International Journal of Biochemistry & Cell Biology, vol. 55, pp. 129–135, 2014. View at Publisher · View at Google Scholar · View at Scopus
  34. S. Nagel, B. Schneider, A. Rosenwald et al., “t(4;8)(q27;q24) in Hodgkin lymphoma cells targets phosphodiesterase PDE5A and homeobox gene ZHX2,” Genes, Chromosomes and Cancer, vol. 50, no. 12, pp. 996–1009, 2011. View at Publisher · View at Google Scholar · View at Scopus
  35. S. Nagel, B. Schneider, C. Meyer, M. Kaufmann, H. G. Drexler, and R. A. Macleod, “Transcriptional deregulation of homeobox gene ZHX2 in Hodgkin lymphoma,” Leukemia research, vol. 36, no. 5, pp. 646–655, 2012. View at Publisher · View at Google Scholar · View at Scopus
  36. I. Gozes, “Activity-dependent neuroprotective protein: from gene to drug candidate,” Pharmacology & Therapeutics, vol. 114, no. 2, pp. 146–154, 2007. View at Publisher · View at Google Scholar · View at Scopus
  37. G. Vandeweyer, C. Helsmoortel, A. Van Dijck et al., “The transcriptional regulator ADNP links the BAF (SWI/SNF) complexes with autism,” American Journal of Medical Genetics Part C: Seminars in Medical Genetics, vol. 166, no. 3, pp. 315–326, 2014. View at Publisher · View at Google Scholar · View at Scopus
  38. C. Helsmoortel, A. T. Vulto-van Silfhout, B. P. Coe et al., “A SWI/SNF-related autism syndrome caused by de novo mutations in ADNP,” Nature Genetics, vol. 46, no. 4, pp. 380–384, 2014. View at Publisher · View at Google Scholar · View at Scopus
  39. M. H. Yang, Y. H. Yang, C. Y. Lu et al., “Activity-dependent neuroprotector homeobox protein: a candidate protein identified in serum as diagnostic biomarker for Alzheimer’s disease,” Journal of Proteomics, vol. 75, no. 12, pp. 3617–3629, 2012. View at Publisher · View at Google Scholar · View at Scopus
  40. A. Merenlender-Wagner, A. Malishkevich, Z. Shemer et al., “Autophagy has a key role in the pathophysiology of schizophrenia,” Molecular Psychiatry, vol. 20, no. 1, pp. 126–132, 2015. View at Publisher · View at Google Scholar · View at Scopus
  41. S. Mandel, G. Rechavi, and I. Gozes, “Activity-dependent neuroprotective protein (ADNP) differentially interacts with chromatin to regulate genes essential for embryogenesis,” Developmental Biology, vol. 303, no. 2, pp. 814–824, 2007. View at Publisher · View at Google Scholar · View at Scopus
  42. H. S. Jeon, T. Dracheva, S. H. Yang et al., “SMAD6 contributes to patient survival in non-small cell lung cancer and its knockdown reestablishes TGF-β homeostasis in lung cancer cells,” Cancer Research, vol. 68, no. 23, pp. 9686–9692, 2008. View at Publisher · View at Google Scholar · View at Scopus
  43. Y. J. Kang, J. W. Shin, J. H. Yoon et al., “Inhibition of erythropoiesis by Smad6 in human cord blood hematopoietic stem cells,” Biochemical and Biophysical Research Communications, vol. 423, no. 4, pp. 750–756, 2012. View at Publisher · View at Google Scholar · View at Scopus
  44. K. Pardali, M. Kowanetz, C. H. Heldin, and A. Moustakas, “Smad pathway-specific transcriptional regulation of the cell cycle inhibitor p21WAF1/Cip1,” Journal of Cellular Physiology, vol. 204, no. 1, pp. 260–272, 2005. View at Publisher · View at Google Scholar · View at Scopus
  45. E. Frullanti, F. Colombo, F. S. Falvella et al., “Association of lung adenocarcinoma clinical stage with gene expression pattern in noninvolved lung tissue,” International Journal of Cancer, vol. 131, no. 5, pp. E643–E648, 2012. View at Publisher · View at Google Scholar · View at Scopus
  46. F. R. Mangone, F. Walder, S. Maistro et al., “Smad2 and Smad6 as predictors of overall survival in oral squamous cell carcinoma patients,” Molecular Cancer, vol. 9, no. 1, p. 1, 2010. View at Publisher · View at Google Scholar · View at Scopus
  47. J. Yin, K. Lu, J. Lin et al., “Genetic variants in TGF-β pathway are associated with ovarian cancer risk,” PLoS One, vol. 6, no. 9, article e25559, 2011. View at Publisher · View at Google Scholar · View at Scopus
  48. H. L. Tan, E. Glen, A. Töpf et al., “Nonsynonymous variants in the SMAD6 gene predispose to congenital cardiovascular malformation,” Human Mutation, vol. 33, no. 4, pp. 720–727, 2012. View at Publisher · View at Google Scholar · View at Scopus
  49. H. Xu, J. Fu, S. W. Ha et al., “The CCAAT box-binding transcription factor NF-Y regulates basal expression of human proteasome genes,” Biochimica et Biophysica Acta (BBA)-Molecular Cell Research, vol. 1823, no. 4, pp. 818–825, 2012. View at Publisher · View at Google Scholar · View at Scopus
  50. C. Dai, C. X. Miao, X. M. Xu et al., “Transcriptional activation of human CDCA8 gene regulated by transcription factor NF-Y in embryonic stem cells and cancer cells,” Journal of Biological Chemistry, vol. 290, no. 37, pp. 22423–22434, 2015. View at Publisher · View at Google Scholar · View at Scopus
  51. C. Romier, F. Cocchiarella, R. Mantovani, and D. Moras, “The NF-YB/NF-YC structure gives insight into DNA binding and transcription regulation by CCAAT factor NF-Y,” Journal of Biological Chemistry, vol. 278, no. 2, pp. 1336–1345, 2003. View at Publisher · View at Google Scholar · View at Scopus
  52. J. D. Fleming, G. Pavesi, P. Benatti, C. Imbriano, R. Mantovani, and K. Struhl, “NF-Y coassociates with FOS at promoters, enhancers, repetitive elements, and inactive chromatin regions, and is stereo-positioned with growth-controlling transcription factors,” Genome Research, vol. 23, no. 8, pp. 1195–1209, 2013. View at Publisher · View at Google Scholar · View at Scopus
  53. C. F. Chen, X. He, A. D. Arslan et al., “Novel regulation of nuclear factor-YB by miR-485-3p affects the expression of DNA topoisomerase IIα and drug responsiveness,” Molecular Pharmacology, vol. 79, no. 4, pp. 735–741, 2011. View at Publisher · View at Google Scholar · View at Scopus
  54. H. Ma, X. Yue, L. Gao et al., “ZHX2 enhances the cytotoxicity of chemotherapeutic drugs in liver tumor cells by repressing MDR1 via interfering with NF-YA,” Oncotarget, vol. 6, no. 2, p. 1049, 2015. View at Publisher · View at Google Scholar
  55. A. Ray and B. K. Ray, “Induction of Ras by SAF-1/MAZ through a feed-forward loop promotes angiogenesis in breast cancer,” Cancer Medicine, vol. 4, no. 2, pp. 224–234, 2015. View at Publisher · View at Google Scholar · View at Scopus
  56. L. Jiao, Y. Li, D. Shen et al., “The prostate cancer-up-regulated myc-associated zinc-finger protein (MAZ) modulates proliferation and metastasis through reciprocal regulation of androgen receptor,” Medical Oncology, vol. 30, no. 2, pp. 1–8, 2013. View at Publisher · View at Google Scholar · View at Scopus
  57. R. Britto, S. Umesh, A. S. Hegde et al., “Shift in AP-2α localization characterizes astrocytoma progression,” Cancer Biology & Therapy, vol. 6, no. 3, pp. 413–418, 2007. View at Publisher · View at Google Scholar
  58. B. C. Turner, J. Zhang, A. A. Gumbs et al., “Expression of AP-2 transcription factors in human breast cancer correlates with the regulation of multiple growth factor signalling pathways,” Cancer Research, vol. 58, no. 23, pp. 5466–5472, 1998. View at Google Scholar
  59. C. E. Hoei-Hansen, J. E. Nielsen, K. Almstrup et al., “Transcription factor AP-2 is a developmentally regulated marker of testicular carcinoma in situ and germ cell tumors,” Clinical Cancer Research, vol. 10, no. 24, pp. 8521–8530, 2004. View at Publisher · View at Google Scholar · View at Scopus
  60. T. Nystorm, “Glucose starvation stimulon of Escherichia coli: role of integration host factor in starvation survival and growth phase-dependent protein synthesis,” Journal of Bacteriology, vol. 177, no. 19, pp. 5707–5710, 1995. View at Publisher · View at Google Scholar
  61. H. Bi and C. Zhang, “Integration host factor is required for the induction of acid resistance in Escherichia coli,” Current Microbiology, vol. 69, no. 2, pp. 218–224, 2014. View at Publisher · View at Google Scholar · View at Scopus
  62. D. Charlier, M. Roovers, D. Gigot, N. Huysveld, A. Piérard, and N. Glansdorff, “Integration host factor (IHF) modulates the expression of the pyrimidine-specific promoter of the carAB operons of Escherichia coli K12 and Salmonella typhimurium LT2,” Molecular and General Genetics MGG, vol. 237, no. 1-2, pp. 273–286, 1993. View at Publisher · View at Google Scholar · View at Scopus
  63. S. S. Singh and D. C. Grainger, “H-NS can facilitate specific DNA-binding by RNA polymerase in AT-rich gene regulatory regions,” PLoS Genetics, vol. 9, no. 6, article e1003589, 2013. View at Publisher · View at Google Scholar · View at Scopus
  64. N. P. Tucker, M. G. Hicks, T. A. Clarke et al., “The transcriptional repressor protein NsrR senses nitric oxide directly via a [2Fe-2S] cluster,” PLoS One, vol. 3, no. 11, article e3623, 2008. View at Publisher · View at Google Scholar · View at Scopus
  65. D. F. Browning, D. J. Lee, S. Spiro, and S. J. Busby, “Down-regulation of the Escherichia coli K-12 nrf promoter by binding of the NsrR nitric oxide-sensing transcription repressor to an upstream site,” Journal of Bacteriology, vol. 192, no. 14, pp. 3824–3828, 2010. View at Publisher · View at Google Scholar · View at Scopus
  66. J. D. Partridge, D. M. Bodenmiller, M. S. Humphrys, and S. Spiro, “NsrR targets in the Escherichia coli genome: new insights into DNA sequence requirements for binding and a role for NsrR in the regulation of motility,” Molecular Microbiology, vol. 73, no. 4, pp. 680–694, 2009. View at Publisher · View at Google Scholar · View at Scopus
  67. M. Yamada and M. H. Saier Jr., “Physical and genetic characterization of the glucitol operon in Escherichia coli,” Journal of Bacteriology, vol. 169, no. 7, pp. 2990–2994, 1987. View at Publisher · View at Google Scholar